For the Inventor, By the Inventor

Enter inventor name

Gyeonggi-do, South Korea

Sung Youb Jung

USPTO Granted Patents = 62 (Patent Applications = 23)

CIPO Patents = 28 (Patent Applications = 20)

EPO Patents = 44 (Patent Applications = 73)

Average Co-Inventor Count = 5.4

ph-index = 9

Forward Citations = 288(Granted Patents)

Forward Citations (Not Self Cited) = 211(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Yongin-si, KR (2010 - 2020)
Suwon-si, KR (2010 - 2024)
Hwaseong-si, KR (2019 - 2024)
Gyeonggi-do, KR (2019 - 2024)

Company Filing History:

Hanmi Pharm. Co., Ltd.

Hanmi Science Co., Ltd.

Hanmi Holdings Co., Ltd.

Beijing Hanmi Pharmaceutical Co., Ltd.

5. 1 out of 1,830

Sanofi-a Ventis Deutschland Gmbh

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Therapeutic Enzyme Fusion Protein

Glucagon Derivatives

Non-Peptidic Polymeric Linker

Insulin Analog Complex

Triple Glucagon/GLP-1/GIP Receptor Agonist

Long-Acting Conjugates

IgG Fc Fragment

Oxyntomodulin Derivatives

Diabetes Treatment

Obesity Treatment

Pharmaceutical Composition

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435328 - Therapeutic enzyme fusion protein having a novel structure and use thereof (2025-10-07),

2. 12018060 - Glucagon derivatives (2024-06-25),

3. 11925691 - Non-peptidic polymeric linker compound, conjugate comprising same linker compound, and methods for preparing same linker compound and conjugate (2024-03-12),

4. 11872283 - Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof (2024-01-16),

5. 11752216 - Insulin analog complex with reduced affinity for insulin receptor and use thereof (2023-09-12),

6. 11667688 - Glucagon derivative and a composition comprising a long acting conjugate of the same (2023-06-06),

7. 11530249 - Long-acting conjugates of GLP-2 derivatives (2022-12-20),

8. 11396534 - Insulin analogs with reduced affinity to insulin receptor and use thereof (2022-07-26),

9. 11332508 - Triple glucagon/GLP-1/GIP receptor agonist (2022-05-17),

10. 11261227 - Glucagon derivative and a composition comprising a long acting conjugate of the same (2022-03-01),

11. 11254724 - Glucagon derivatives (2022-02-22),

12. 11147857 - IgG4 Fc fragment comprising modified hinge region (2021-10-19),

13. 11142559 - Glucagon derivative, conjugate thereof, composition comprising same, and therapeutic use thereof (2021-10-12),

14. 11135271 - Glucagon derivatives with improved stability (2021-10-05),

15. 11058776 - IgG Fc fragment for a drug carrier and method for the preparation thereof (2021-07-13),

Title: The Innovative Mind of Sung Youb Jung

Introduction: Sung Youb Jung is a pioneering inventor hailing from Gyeonggi-do, South Korea, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sung Youb Jung holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Sung Youb Jung has consistently pushed the boundaries of innovation, with a focus on developing cutting-edge technologies that have the potential to revolutionize industries.

Collaborations: Sung Youb Jung has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life, fostering a culture of innovation and collaboration in the tech community.

Conclusion: Sung Youb Jung's relentless pursuit of innovation and his passion for creating transformative technologies have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…